Reply: DOACs for AF After TAVR: Are DOACs Really on First Base?

Hideyuki Kawashima; Yusuke Watanabe; Hirofumi Hioki; Ken Kozuma; Masanori Yamamoto; Kentaro Hayashida

doi:https://doi.org/10.1016/j.jcin.2020.12.030

Reply: DOACs for AF After TAVR: Are DOACs Really on First Base?

Hideyuki Kawashima, Yusuke Watanabe, Hirofumi Hioki, Ken Kozuma, Masanori Yamamoto, Kentaro Hayashida

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	481-482
Number of pages	2
Journal	JACC. Cardiovascular interventions
Volume	14
Issue number	4
DOIs	https://doi.org/10.1016/j.jcin.2020.12.030
Publication status	Published - 22 Feb 2021

Access to Document

https://doi.org/10.1016/j.jcin.2020.12.030

Cite this

@article{7dd5674a56cf47ae97762a2b3d80645b,

title = "Reply: DOACs for AF After TAVR: Are DOACs Really on First Base?",

author = "Hideyuki Kawashima and Yusuke Watanabe and Hirofumi Hioki and Ken Kozuma and Masanori Yamamoto and Kentaro Hayashida",

note = "Funding Information: The OCEAN-TAVI registry is supported by Edwards Lifesciences, Medtronic, Boston Scientific, and Daiichi-Sankyo Company. Drs. Watanabe and Yamamoto have been clinical proctors for Edwards Lifesciences and Medtronic. Dr. Hayashida has been a clinical proctor for Edwards Lifesciences. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.",

year = "2021",

month = feb,

day = "22",

doi = "https://doi.org/10.1016/j.jcin.2020.12.030",

language = "English",

volume = "14",

pages = "481--482",

journal = "JACC. Cardiovascular interventions",

issn = "1936-8798",